| An easy and efficient inducible CRISPR/Cas9 platform with improved specificity for multiple gene targeting J Cao, L Wu, SM Zhang, M Lu, WKC Cheung, W Cai, M Gale, Q Xu, Q Yan Nucleic acids research 44 (19), e149-e149, 2016 | 266 | 2016 |
| Structural basis for KDM5A histone lysine demethylase inhibition by diverse compounds JR Horton, X Liu, M Gale, L Wu, JR Shanks, X Zhang, PJ Webber, ... Cell chemical biology 23 (7), 769-781, 2016 | 105 | 2016 |
| Acquired resistance of EGFR-mutant lung adenocarcinomas to afatinib plus cetuximab is associated with activation of mTORC1 V Pirazzoli, C Nebhan, X Song, A Wurtz, Z Walther, G Cai, Z Zhao, P Jia, ... Cell reports 7 (4), 999-1008, 2014 | 86 | 2014 |
| Screen-identified selective inhibitor of lysine demethylase 5A blocks cancer cell growth and drug resistance M Gale, J Sayegh, J Cao, M Norcia, P Gareiss, D Hoyer, JS Merkel, Q Yan Oncotarget 7 (26), 39931, 2016 | 79 | 2016 |
| Acquired resistance to HER2-targeted therapies creates vulnerability to ATP synthase inhibition M Gale, Y Li, J Cao, ZZ Liu, MA Holmbeck, M Zhang, SM Lang, L Wu, ... Cancer Research 80 (3), 524-535, 2020 | 43 | 2020 |
| High-throughput screening to identify inhibitors of lysine demethylases M Gale, Q Yan Epigenomics 7 (1), 57-65, 2015 | 25 | 2015 |
| DNA methylation in multiple myeloma is weakly associated with gene transcription S Jung, S Kim, M Gale, I Cherni, R Fonseca, J Carpten, B Salhia PloS one 7 (12), e52626, 2012 | 23 | 2012 |
| Differential effects of AKT1 (p. E17K) expression on human mammary luminal epithelial and myoepithelial cells B Salhia, C Van Cott, T Tegeler, A Polpitiya, RA DuQuette, M Gale, ... Human mutation 33 (8), 1216-1227, 2012 | 16 | 2012 |
| The molecular basis of histone demethylation JR Horton, M Gale, Q Yan, X Cheng DNA and Histone Methylation as Cancer Targets, 151-219, 2017 | 9 | 2017 |
| An easy and efficient inducible CRISPR J Cao Cas9 platform with improved specificity for multiple gene targeting, e149, 2016 | 3 | 2016 |
| Identification of Small Molecule Inhibitors of Jumonji AT-Rich Interactive Domain 1A (JARID1A) Histone Demethylase Q Yan, M Gale, D Hoyer, J Sayegh, J Cao, P Gareiss US Patent App. 16/099,790, 2019 | 1 | 2019 |
| The role of the histone demethyltransferase gene JMJD1C and H3K9 methylation in multiple myeloma J LoBello, M Gale, A Watanabe, G Hostetter, R Fonseca, B Salhia Blood 120 (21), 3527, 2012 | 1 | 2012 |
| Supplementary Figures 1-11, Table 1, method and references from Acquired Resistance to HER2-Targeted Therapies Creates Vulnerability to ATP Synthase Inhibition Q Yan, X Chen, GS Shadel, DL Rimm, DF Stern, MP DiGiovanna, ... (No Title), 2023 | | 2023 |
| Identification of small molecule inhibitors of JARID1B histone demethylase J Sayegh, M Gale, J Cao, MR Zou, A Morales, M Norcia, D Hoyer, ... | | 2013 |
Qin YanYale School of MedicineVerified email at yale.edu